ArticleQuantitative imaging in medicine and surgery2026
Diagnostic performance and dose reduction of virtual noncontrast imaging in pediatric computed tomography urography.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography urography (CTU) is critical to diagnosis in pediatric urology, but conventional four-phase protocols entail substantial cumulative radiation exposure. Minimizing radiation while preserving diagnostic efficiency is paramount in pediatric imaging. This study aimed to evaluate the diagnostic performance of dual-source dual-energy computed tomography (DECT)-derived virtual noncontrast (VNC) images as a substitute for true noncontrast (TNC) images and to assess the feasibility of omitting the unenhanced scans in pediatric CTU. Methods: This retrospective, single-center, intraindividual paired comparative study reviewed 217 consecutive pediatric patients who underwent four-phase dual-source DECT urography between June 2022 and December 2024. The protocol included a TNC scan, dual-energy corticomedullary/arterial and nephrographic/venous phases (reconstructed from the arterial phase and venous phase, respectively), and an excretory phase. The computed tomography (CT) attenuation, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and subjective image quality scores were compared between VNC and TNC images across normal anatomical structures and various urological lesions (tumors, hydronephrosis, cysts, calculi, trauma, and malformations). Statistical analyses included paired the Student Results: VNC significantly underestimated the CT attenuation of renal calculi compared to TNC [mean difference ~330 Hounsfield units (HU)]. Subcutaneous fat attenuation was slightly higher on VNC (mean bias <2.82 HU; P<0.001). For other soft-tissue regions, VNC attenuation was slightly lower than TNC (difference <8.62 HU), showing moderate-to-excellent agreement. VNC yielded lower image noise (P<0.001) and a similar or higher CNR when compared with TNC scans. Subjective image quality scores for VNC images were ≥3 in all but one patient, satisfying diagnostic requirements. Omitting the baseline TNC phase reduced the cumulative effective radiation dose by 24.6% (from 7.98±1.71 to 6.02±1.28 mSv). Conclusions: DECT-derived VNC and conventional TNC images demonstrate comparable density resolution and overall image quality, with no significant differences in SNR, CNR, or noise between the two VNC phases (P>0.017). VNC can safely replace TNC scans for routine anatomical evaluation and lesion detection in pediatric CTU, significantly reducing the radiation dose. However, a TNC scan remains necessary for the accurate quantitative assessment of renal calculi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.